儿科药物诱导肝损伤的预测建模:动态分类器选择与集群分析分析
Zixin Shi1, Linjun Huang1, Haolin Wang1
1College of Medical Informatics, Chongqing Medical University, Chongqing, China.
Digital health
|March 24, 2025
概括
这项研究通过将集群与动态分类器选择相结合,提高了对儿童药物诱导性肝损伤 (DILI) 的预测. 新的框架提高了准确性,以提高儿科患者的安全性和临床决策.
科学领域:
- 儿科药理学和毒理学
- 临床信息学和机器学习
- 生物医学数据科学是生物医学数据科学.
背景情况:
- 由于发育因素,儿童群体对药物诱导性肝损伤 (DILI) 具有独特的脆弱性.
- 由于复杂的病例和有限的数据,对儿童进行准确的DILI鉴定具有挑战性.
- 现有的方法在儿科DILI预测中与患者异质性和不平衡的数据集作斗争.
研究的目的:
- 开发和验证一个先进的计算框架,以改善儿科DILI预测.
- 解决儿科DILI评估中患者异质性和数据不平衡的挑战.
- 通过优化儿科患者的DILI风险分层来增强临床决策.
主要方法:
- 分析了12555名儿科住院患者的回顾性队列.
- 集群分析将患者分为四个不同的子组.
- 实现了具有多个分类器行为 (DCS-MCB) 的动态分类器选择,优化了每个子组的模型选择.
主要成果:
- 集群增强的DCS-MCB框架显著超过了传统的机器学习模型.
- 合体学习模型显示出优异的预测性能.
- 该研究实现了高性能指标:F1得分 (0.926),MCC (0.917) 和G-平均值 (0.959).
结论:
- 集群和动态分类器选择的综合方法对于儿科DILI预测是有效的.
- 这种方法为儿科患者的药物安全监测提供了一个强大而适应性的框架.
- 这些发现支持加强患者分层和改善儿科DILI管理的临床结果.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
31
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
31
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
54
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
54
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
23
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
23
Nonlinear Pharmacokinetics: Overview
230
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
230
Mechanistic Models: Overview of Compartment Models
52
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
52
Analysis of Population Pharmacokinetic Data
205
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
205


